YDES
NASDAQ · Biotechnology
Yd Bio Ltd
$6.95
+0.56 (+8.68%)
Open$6.20
Previous Close$6.40
Day High$7.14
Day Low$6.03
52W High$15.72
52W Low$1.70
Volume—
Avg Volume100.1K
Market Cap530.65M
P/E Ratio—
EPS$-0.03
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 679.5K | 122.20M | 119.09M |
| Net Income | -9,513,536 | 29.08M | 25.78M |
| Profit Margin | -1,392.6% | 23.8% | 21.7% |
| EBITDA | -6,016,586 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |